30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Cytokinetics Inc (CYTK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Partner Fund Management Christopher Medlock James | 1,757,192 | $146,707,960 | -27% | 8.79% |
| 2. | Logos Capital Arsani William | 1,625,000 | $135,671,250 | +30% | 12.66% |
| 3. | Polar Capital Brian Ashford-Russell And Tim Woolley | 1,417,054 | $118,309,838 | -47% | 0.72% |
| 4. | 1,347,300 | $112,486,077 | 3.75% | ||
| 5. | Millennium Management Israel Englander | 1,199,341 | $100,132,980 | +72% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.57 | 6,000 | Director | 6,250 | 2019-11-19 | Filing | |
| $9.52 | 8,506 | Large Shareholder | 499,312 | 2019-12-11 | Filing | |
| $9.52 | 49,804 | Large Shareholder | 2,861,622 | 2019-12-11 | Filing | |
| $9.52 | 60,103 | Large Shareholder | 3,617,776 | 2019-12-11 | Filing | |
| $9.40 | 15,030 | Large Shareholder | 490,806 | 2019-12-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $74.32 | 4,000 | Officer | 138,567 | 2024-04-09 | Filing | |
| $74.31 | 28,605 | Officer | 142,567 | 2024-04-09 | Filing | |
| $67.56 | 28,604 | Officer | 138,973 | 2024-03-05 | Filing | |
| $67.53 | 4,000 | Officer | 138,973 | 2024-03-05 | Filing | |
| $76.48 | 5,000 | Director | 42,632 | 2024-02-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,102,070 | $1,344,361,823 | 0.03% | |
| 2. | 13,007,783 | $1,086,019,844 | 0.08% | |
| 3. | 11,016,889 | $919,800,063 | 0.02% | |
| 4. | 6,488,500 | $541,724,865 | 0.1% | |
| 5. | 5,893,358 | $492,036,459 | 0.02% |
News See All
Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2023 Earnings Call Transcript
Cytokinetics, Incorporated misses on earnings expectations. Reported EPS is $-1.38 EPS, expectations were $-1.03.
5 Best Russell 2000 Stocks To Buy According To Hedge Funds
In this article, we discuss 5 best Russell 2000 stocks to buy.
Cytokinetics, Incorporated (CYTK) Rose on Successful Clinical Trial
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
11 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts.
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics Third Quarter 2023 Conference Call.
10 Biotech Stocks with Biggest Upside
In this article, we discuss 12 biotech stocks with biggest upside.
15 Worst Performing Biotech Stocks in 2023
In this article, we discuss 15 worst performing biotech stocks in 2023.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics Second Quarter 2020 Conference Call.
Billionaire Hedge Funds
